NeuBase Therapeutics, Inc. (NBSE) Social Stream



NeuBase Therapeutics, Inc. (NBSE): $1.01

-0.04 (-3.81%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NBSE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 427

in industry

Featured Post From StockTwits About NBSE

$NBSE I don't really play in the pre product biotech space , with the exception being a potential drug development platform like crispr or rna . I was in $CRSP $NTLA $ALNY way early and way before Cathie $ARKG

This is super f* high risk, only $150 mil market cap but a really strong team.

In my opinion this can be 100 bagger or it can be a zero if it doesn't work.

For those looking for super high risk reward , this is a very strong play. Some want to get in early, that's what I did and put it in all accounts. Safer entries after trials get to phase 2 or 3 , and they will need more money so dilution is coming so after a fundraising. But if u want something at 150 mil cap that has 100 bagger potential this is it, size and risk accordingly
AlphaRR, published August 2, 2021

What Else are NBSE Traders Talking About?


Other tickers frequently mentioned alongside NBSE are CRSP, NTLA, ALNY and ARKG.

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6395 seconds.